Niranjan Sardesai - Net Worth and Insider Trading
Niranjan Sardesai Net Worth
The estimated net worth of Niranjan Sardesai is at least $42,661 dollars as of 2024-04-27. Niranjan Sardesai is the COO of Inovio Pharmaceuticals Inc and owns about 4,036 shares of Inovio Pharmaceuticals Inc (INO) stock worth over $42,661. Details can be seen in Niranjan Sardesai's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Niranjan Sardesai has not made any transactions after 2016-08-29 and currently still holds the listed stock(s).
Transaction Summary of Niranjan Sardesai
Niranjan Sardesai Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Niranjan Sardesai owns 1 companies in total, including Inovio Pharmaceuticals Inc (INO) .
Click here to see the complete history of Niranjan Sardesai’s form 4 insider trades.
Insider Ownership Summary of Niranjan Sardesai
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INO | Inovio Pharmaceuticals Inc | 2016-08-29 | Chief Operating Officer |
Niranjan Sardesai Latest Holdings Summary
Niranjan Sardesai currently owns a total of 1 stock. Niranjan Sardesai owns 4,036 shares of Inovio Pharmaceuticals Inc (INO) as of August 29, 2016, with a value of $42,661.
Latest Holdings of Niranjan Sardesai
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INO | Inovio Pharmaceuticals Inc | 2016-08-29 | 4,036 | 10.57 | 42,661 |
Holding Weightings of Niranjan Sardesai
Niranjan Sardesai Form 4 Trading Tracker
According to the SEC Form 4 filings, Niranjan Sardesai has made a total of 0 transactions in Inovio Pharmaceuticals Inc (INO) over the past 5 years. The most-recent trade in Inovio Pharmaceuticals Inc is the sale of 1,817 shares on August 29, 2016, which brought Niranjan Sardesai around $202,740.
Insider Trading History of Niranjan Sardesai
- 1
Niranjan Sardesai Trading Performance
GuruFocus tracks the stock performance after each of Niranjan Sardesai's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Niranjan Sardesai is 23.49%. GuruFocus also compares Niranjan Sardesai's trading performance to market benchmark return within the same time period. The performance of stocks bought by Niranjan Sardesai within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Niranjan Sardesai's insider trading performs compared to the benchmark.
Performance of Niranjan Sardesai
Average Return
185.05%
Outperforming Transactions
75%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.63 | 23.49 | 90.77 | 185.05 | 58.19 | 24.9 |
| Relative Return to S&P 500(%) | 4.6 | 18.09 | 83.81 | 168.69 | 44.15 | 12.5 |
Niranjan Sardesai Ownership Network
Ownership Network List of Niranjan Sardesai
Ownership Network Relation of Niranjan Sardesai
Niranjan Sardesai Owned Company Details
What does Inovio Pharmaceuticals Inc do?
Who are the key executives at Inovio Pharmaceuticals Inc?
Niranjan Sardesai is the Chief Operating Officer of Inovio Pharmaceuticals Inc. Other key executives at Inovio Pharmaceuticals Inc include Chief Medical Officer Michael John Sumner , Chief Scientific Officer Laurent Humeau , and CFO Peter Kies .
Inovio Pharmaceuticals Inc (INO) Insider Trades Summary
Over the past 18 months, Niranjan Sardesai made no insider transaction in Inovio Pharmaceuticals Inc (INO). Other recent insider transactions involving Inovio Pharmaceuticals Inc (INO) include a net sale of 17,501 shares made by David B. Weiner , and a net sale of 5,700 shares made by Lota S. Zoth .
In summary, during the past 3 months, insiders sold 0 shares of Inovio Pharmaceuticals Inc (INO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,933 shares of Inovio Pharmaceuticals Inc (INO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,933 shares.
Inovio Pharmaceuticals Inc (INO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inovio Pharmaceuticals Inc Insider Transactions
Niranjan Sardesai Mailing Address
Above is the net worth, insider trading, and ownership report for Niranjan Sardesai. You might contact Niranjan Sardesai via mailing address: Vgx Pharmaceuticals, Inc., 450 Sentry Parkway, Blue Bell Pa 19422.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
